These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 39170287)
1. High expression levels of S1PR3 and PDGFRB indicates unfavorable clinical outcomes in colon adenocarcinoma. Yu M; Zhang K; Wang S Heliyon; 2024 Aug; 10(15):e35532. PubMed ID: 39170287 [TBL] [Abstract][Full Text] [Related]
2. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794 [TBL] [Abstract][Full Text] [Related]
3. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904 [No Abstract] [Full Text] [Related]
4. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y Front Oncol; 2022; 12():876660. PubMed ID: 35747790 [TBL] [Abstract][Full Text] [Related]
5. Pancancer analysis of NDUFA4L2 with focused role in tumor progression and metastasis of colon adenocarcinoma. Zhou R; Sun Z; Zhou R; Wang M; Zhuo Q; Deng X; Wang Z; Xu Y Med Oncol; 2024 Oct; 41(11):285. PubMed ID: 39402288 [TBL] [Abstract][Full Text] [Related]
6. INSC Is Down-Regulated in Colon Cancer and Correlated to Immune Infiltration. Yu T; Li D; Zeng Z; Xu X; Zhang H; Wu J; Song W; Zhu H Front Genet; 2022; 13():821826. PubMed ID: 35664320 [No Abstract] [Full Text] [Related]
7. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma. He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071 [TBL] [Abstract][Full Text] [Related]
8. High expression of NXPH4 correlates with poor prognosis, metabolic reprogramming, and immune infiltration in colon adenocarcinoma. Sun Z; Wang H; Xu Y; Liu Y; Wang L; Zhou R; Zhou R; Ma W; Zhang T J Gastrointest Oncol; 2024 Apr; 15(2):641-667. PubMed ID: 38756632 [TBL] [Abstract][Full Text] [Related]
9. Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma. Wang Y; Lin MG; Meng L; Chen ZM; Wei ZJ; Ying SC; Xu A Front Oncol; 2022; 12():941156. PubMed ID: 36505813 [TBL] [Abstract][Full Text] [Related]
10. Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes. Liu Y; Zhao Y; Zhang S; Rong S; He S; Hua L; Wang X; Chen H Sci Rep; 2024 Jan; 14(1):1655. PubMed ID: 38238555 [TBL] [Abstract][Full Text] [Related]
11. High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma. Yang Y; Ye F; Xia T; Wang Q; Zhang Y; Du J BMC Cancer; 2022 May; 22(1):487. PubMed ID: 35501725 [TBL] [Abstract][Full Text] [Related]
12. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis. Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y Front Genet; 2022; 13():816173. PubMed ID: 35281843 [No Abstract] [Full Text] [Related]
13. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma. Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y Front Immunol; 2022; 13():1038927. PubMed ID: 36451813 [TBL] [Abstract][Full Text] [Related]
14. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma. Yang M; He H; Peng T; Lu Y; Yu J Comput Intell Neurosci; 2022; 2022():8598046. PubMed ID: 35392038 [TBL] [Abstract][Full Text] [Related]
15. Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma. Wang H; Wang W; Wang Z; Li X Front Immunol; 2023; 14():1291859. PubMed ID: 38143740 [TBL] [Abstract][Full Text] [Related]
16. Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma. Xiang J; Gong W; Liu J; Zhang H; Li M; Wang R; Lv Y; Sun P Front Genet; 2023; 14():1098190. PubMed ID: 37274780 [No Abstract] [Full Text] [Related]
17. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma. Miao YD; Kou ZY; Wang JT; Mi DH World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046 [TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Prognostic Model based on 11 E3-related Genes for Colon Cancer Patients. JIang W; Dong J; Zhang W; Huang Z; Guo T; Zhang K; Jiang X; Du T Curr Pharm Des; 2024; 30(12):935-951. PubMed ID: 38898815 [TBL] [Abstract][Full Text] [Related]
19. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma. Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K Front Oncol; 2022; 12():904464. PubMed ID: 35912258 [TBL] [Abstract][Full Text] [Related]
20. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma. Tan Y; Lu L; Liang X; Chen Y World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]